An experimental drug that slows blood flow in the brain knocks out migraine headaches in some people, researchers report in the March 11 New England Journal of Medicine.
The drug, known only as BIBN 4096 BS so far, competes in the body with the natural compound CGRP, or calcitonin gene-related peptide, says study coauthor Jes Olesen of the University of Copenhagen and Glostrup Hospital in Copenhagen, Denmark.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.